FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma

FTY720 is an immunosuppressant developed to prevent organ transplant rejection. Recent studies indicate an additional role for FTY720 in inducing cell apoptosis. We demonstrate here that FTY720 mediates toxic effects in cell lines representing different B-cell malignancies and primary B cells from p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Liu, Qing, Zhao, Xiaobin, Frissora, Frank, Ma, Yihui, Santhanam, Ramasamy, Jarjoura, David, Lehman, Amy, Perrotti, Danilo, Chen, Ching-Shih, Dalton, James T., Muthusamy, Natarajan, Byrd, John C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2008
Soggetti:
Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2200813/
https://ncbi.nlm.nih.gov/pubmed/17761520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-10-053884
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi